Darren Ae Cross (Darren Cross)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 10

Top Topics

Chronic Myeloid Leukemia

Tyrosine Kinase

Top Venues

Nature communications

Nature reviews. Drug discovery

Science translational medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Ryan J Hartmaier, Aleksandra A Markovets, Myung-Ju Ahn, Lecia V Sequist, Ji-Youn Han, Byoung Chul Cho, Helena Alexandra Yu, Sang-We Kim, James Chih-Hsin Yang, Jong Seok Lee, Wu-Chou Su, Dariusz Mirosław Kowalski, Sergey V Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren Ae Cross, Nisha Kurian, Mireille Cantarini, Pasi A Janne
Osimertinib+Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor Mutated MET-Amplified Non-Small Cell Lung Cancer: TATTON. Cancer discovery (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Sally J Adua, Anna Arnal-Estape, Minghui Zhao, Bowen Qi, Zongzhi Z Liu, Carolyn Kravitz, Heather Hulme, Nicole Strittmatter, Francesc Lopez, Sampada Chande, Alexandra E Albert, Mary-Ann Melnick, Bomiao Hu, Katerina Politi, Veronica Chiang, Nicola Colclough, Richard J A Goodwin, Darren Ae Cross, Paul D Smith, Don X Nguyen
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. Nature communications 13 (1) (2022)
Philip Cohen, Darren Ae Cross, Pasi A Janne
Kinase drug discovery 20 years after imatinib: progress and future directions. Nature reviews. Drug discovery 20 (7) (2021)
Pınar Özden Eser, Raymond M Paranal, Jieun Son, Elena Ivanova, Yanan Kuang, Heidi M Haikala, Ciric To, Jeffrey J Okoro, Kshiti H Dholakia, Jihyun Choi, Yoonji Eum, Atsuko Ogino, Pavlos Missios, Dalia Ercan, Man Xu, Michael J Poitras, Stephen Wang, Kenneth H Ngo, Michael Dills, Masahiko Yanagita, Timothy Lopez, Mika Lin, Jeanelle Tsai, Nicolas Floch, Emily S Chambers, Jennifer Heng, Rana Anjum, Alison D Santucci, Kesi S Michael, Alwin G Schuller, Darren Ae Cross, Paul D Smith, Geoffrey R Oxnard, David A Barbie, Lynette M Sholl, Magda Bahcall, Sangeetha Palakurthi, Prafulla C Gokhale, Cloud P Paweletz, George Q Daley, Pasi A Janne
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer. Science translational medicine 13 (609) (2021)